- Home
- ANIX vs ASRT Comparison
ANIX vs ASRT Comparison
Compare ANIX & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- ASRT
- Stock Information
- Founded
- ANIX 1982
- ASRT 1995
- Country
- ANIX United States
- ASRT United States
- Employees
- ANIX N/A
- ASRT N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- ANIX Health Care
- ASRT Health Care
- Exchange
- ANIX Nasdaq
- ASRT Nasdaq
- Market Cap
- ANIX 95.7M
- ASRT 79.1M
- IPO Year
- ANIX 1987
- ASRT 1997
- Fundamental
- Price
- ANIX $2.94
- ASRT $0.81
- Analyst Decision
- ANIX Strong Buy
- ASRT Strong Buy
- Analyst Count
- ANIX 3
- ASRT 1
- Target Price
- ANIX $9.00
- ASRT $3.00
- AVG Volume (30 Days)
- ANIX 64.6K
- ASRT 180.3K
- Earning Date
- ANIX 09-10-2025
- ASRT 11-10-2025
- Dividend Yield
- ANIX N/A
- ASRT N/A
- EPS Growth
- ANIX N/A
- ASRT N/A
- EPS
- ANIX N/A
- ASRT N/A
- Revenue
- ANIX N/A
- ASRT $117,099,000.00
- Revenue This Year
- ANIX N/A
- ASRT N/A
- Revenue Next Year
- ANIX N/A
- ASRT $5.84
- P/E Ratio
- ANIX N/A
- ASRT N/A
- Revenue Growth
- ANIX N/A
- ASRT N/A
- 52 Week Low
- ANIX $2.07
- ASRT $0.51
- 52 Week High
- ANIX $4.20
- ASRT $1.38
- Technical
- Relative Strength Index (RSI)
- ANIX 43.29
- ASRT 58.16
- Support Level
- ANIX $2.93
- ASRT $0.78
- Resistance Level
- ANIX $3.09
- ASRT $0.83
- Average True Range (ATR)
- ANIX 0.11
- ASRT 0.03
- MACD
- ANIX 0.00
- ASRT -0.00
- Stochastic Oscillator
- ANIX 1.85
- ASRT 48.45
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.